Oral vs injectable diclofenac: what the 2004 trial actually found

What did @doctorvonludwig actually say?

The claim is straightforward: a 2004 Hong Kong trial found that 75 mg intramuscular diclofenac sodium and 75 mg oral diclofenac potassium produced "exactly the same" pain relief at two hours, even though the injection worked faster initially. The practical conclusion offered was that tablets win on convenience because "you can take them home."

That's a fairly reasonable read of a real, published paper. Ho and Chung (2004) in the Hong Kong Journal of Emergency Medicine did run a prospective randomised trial in an emergency department setting comparing those two formulations head-to-head in acute pain patients. The creator named the study in the caption, which is more than most TikTok health accounts bother to do. Credit where it's due.

Does the science back this up?

Mostly, yes, with some important caveats the video skips over. Ho and Chung (2004) found that IM diclofenac sodium produced faster onset of analgesia, but by the two-hour mark, pain scores between the two groups were not statistically different. That part checks out.

The broader literature supports the general principle. A Cochrane review by Derry et al. (2015, Cochrane Database of Systematic Reviews) on single-dose oral diclofenac for acute postoperative pain found that oral formulations are highly effective when absorption isn't compromised. The bioavailability argument for injections is real but frequently overstated in clinical settings where patients can swallow and have functioning GI tracts. Diclofenac potassium, specifically, is a faster-absorbing salt form compared to diclofenac sodium tablets, which matters for the comparison the creator is describing. That nuance is missing from the video.

What did they get wrong (or right)?

The creator got the headline finding right. Where things get sloppy is in the word "exactly." Pain relief at two hours being statistically equivalent is not the same as being identical. The Ho and Chung trial had 52 patients, which is a small sample. Calling that result "exactly the same" overstates the precision of a modestly powered single-centre trial from 2004.

There's also a silent assumption that these findings generalise broadly. The trial was conducted in an emergency department with acute pain patients who could take oral medication. Patients in severe pain, vomiting, or with GI absorption issues are a different story entirely. The injection isn't irrelevant; it just has a narrower clinical advantage than most people assume in patients who can tolerate oral dosing.

The category tag on this video is TRT, which makes zero sense for a diclofenac pharmacology discussion. That's a platform categorisation issue, but worth flagging because it shapes who sees this content and in what context.

What should you actually know?

The form of diclofenac matters more than the route alone. Diclofenac potassium (the oral form used in this trial) absorbs faster than diclofenac sodium tablets, which is why the oral group held up as well as it did at two hours. This is not a universal finding for all oral NSAIDs versus their injectable counterparts.

For most people in an outpatient or emergency setting who can take oral medication, the evidence does support oral diclofenac as a legitimate first-line option. The injection is not automatically superior just because it bypasses the gut. However, individual clinical context, kidney function, cardiovascular risk, and GI history all affect whether diclofenac in any form is appropriate. A 20-second TikTok is not the place to sort that out for your specific situation. Talk to a prescribing clinician before deciding the shot is unnecessary or the tablets are sufficient for your case.